Warning to anyone who suffered a ‘spring cold' as new study raises fears over male fertility
Click to share on Facebook (Opens in new window)
MEN struck down by a 'spring cold' could be at risk of fertility issues, a new study suggests.
Scientists in China found men who caught the Omicron Covid variant - still spreading widely in the UK - had weaker, more damaged sperm than those who didn't.
Sign up for Scottish Sun
newsletter
Sign up
1
Even a mild bout of Covid might damage sperm
Credit: Getty
The virus is now so common - and symptoms often so mild - that many mistake it for a typical seasonal sniffle.
Recent data from the UK Health Security Agency (UKHSA), as of April 2025, suggests Covid cases are creeping up, with test positivity in hospitals having risen from 4.2 per cent to 4.9 per cent in just two weeks.
And while hospital admissions remain low, this new study suggests the virus could quietly be affecting men's fertility, up to a month after recovery.
A previous study, published in the Journal Reproduction in 2021, found severe cases of Covid might impact the quality of a man's sperm.
Experts not involved in the research warned, at the time, that being ill from any virus such as flu can temporarily drop sperm count (sometimes to zero) for a few weeks or months.
"This makes it difficult to work out how much of the reductions observed in this study were specific to Covid rather than just from being ill,' said Dr Channa Jayasena, from Imperial College London, in an email to CNN.
The latest study, published in Scientific Reports, looked how how badly a mild Omicron Covid infection impacted men's sperm quality over a month.
To investigate this, experts from China Medical University in Shenyang analysed the sperm of over 600 men - all of whom were seeking fertility treatment at a specialised centre.
This included 140 who gave samples both before and after infection, and 149 healthy men who tested negative throughout.
They also looked at 515 previously infected men in a separate study, comparing them with 89 men who never caught the bug.
Dr Philippa Kaye answers the web's most EMBARRASSING women's sex questions
One month after testing postive nearly 58 per cent showed reduced sperm count, and around 69 per cent had poorer sperm motility, which is how well sperm move.
The most dramatic fall was seen in the fastest, highest-quality sperm, with 71 per cent showing a drop.
And DNA damage, known to affect pregnancy rates and even increase miscarriage risk, was found in 75 per cent of men post-Covid.
"Further research is needed to observe the long-term effect of Covid on sperm quality or reproductive outcomes," the scientists wrote in the paper.
"There may be a need to constantly monitor the SARS-CoV-2 infection and integrate screening and diagnosis of the disease in the management of male infertility," they added.
5 ways to boost your chances of being a dad
Dr Amit Shah, leading fertility expert and co-founder of Fertility Plus, shares tips that will increase male fertility over time: Eat a healthy well-balanced diet with lots of vegetables and protein, such as Brazil nuts, fish, meat, poultry, eggs and wholegrain cereal.
Aim for a healthy body weight (BMI between 18.5 and 24) with regular exercise, even if it is a 45-minute walk four times a week.
Keep alcohol intake down, so no binge drinking and ideally less than ten units a week (a pint of lager is roughly 2-3 units).
Cut out smoking, which deteriorates sperm health.
Don't sit and suffer. Seek help from professionals.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mirror
2 hours ago
- Daily Mirror
Nolans Sister Anne's health update after cancer battle - 'I don't want to die'
The 74-year-old, who has battled breast cancer twice, lost sisters Bernie and Linda to the disease When a letter with an NHS stamp dropped on Anne Nolan 's doormat, she held her breath for a moment. It had been five years since she'd been diagnosed with breast cancer for the second time, then having to undergo surgery before enduring chemotherapy and radiotherapy. Every test since had been clear but fear consumed Anne, 74, and she pushed the letter to one side. She'd tragically lost sisters Bernie and Linda to the disease and the devastation of them no longer being around still cuts deep. 'If it was bad news, I don't know how I was going to handle it,' she admitted. Eventually drumming up the courage and strength to find out her fate, the tears started rolling when Anne read she was officially cancer-free. 'It was great news,' she says. 'It said I was all clear and it hadn't spread anywhere else. I had a little cry. I was very emotional. I was just relieved more than anything and I felt so blessed and so happy.' The happiness was tinged with sadness though, as Anne's thoughts turned to little sisters Linda and Bernie. 'Although I was absolutely thrilled, I did think about them,' she opened up. "I didn't feel guilty because it's nothing to do with me but I did feel sad that they weren't as lucky as I was. It's an emotional thing for me to think about them not surviving and then I did survive. But that's just the luck of the draw.' Linda passed away in January. She was 65. Her initial cancer was in the breast which spread to other parts of her body. Bernie died in 2013 aged 52 of the same disease. Speaking from her Blackpool home, she said: 'I don't really like to hear when people say, 'You've fought your cancer' because it makes people who've died of cancer didn't fight hard enough. I think I've just been lucky. I always consider myself lucky when I look at my two sisters. Linda went through a terrible time and so did Bernie.' Although her chemotherapy was gruelling, Anne says she fared better than those around her also battling the disease. Diagnosed with her first cancer in 2000 and her second 20 years later, both were caught early with treatment starting within two weeks both times. But her 2022 experience has left lasting scars on Anne's mental health. 'It was really awful,' she explained. 'I ended us having anxiety about dying. I've had to have tablets from the doctor for anxiety because of having cancer during COVID. I wasn't allowed to be with my family. I was in hospital for 11 days. And nobody could visit me except my sister-in-law and my brother-in-law both worked at the hospital. It was horrendous. I still have anxiety but it's not as bad. I have anxieties about dying. It is about the cancer coming back as well. That's why I didn't want to open the letter. I don't want to die, I love being alive. I love being here.' Anne has a lot to live for. She beams when she talks about her two daughters - Amy, 44, and Alex, 37, and three grandchildren Vinny, 15, Ryder, 13, and Navaeh, 10. 'I want to see them grow up,' she pleads. 'My granddaughter plays football. I was watching the Lionesses in the Euros because I'm a massive football fan. And I'm thinking, 'God, if I live for another 10 years, Niamh might be playing for the Lionesses by the time.' That's what I keep thinking. Vinny plays football and Ryder plays guitar. Please let me live until they get older and they remember me and I can see what they're going to do with their lives.' As one of the famous Nolan sisters, she's also got her close-knit family to lean on. She rose to fame when their band, made up of her Maureen, Linda, Denise, Bernie and Coleen with hits I'm In The Mood for Dancing and Gotta Pull Myself Together. Anne says her ill health has made her want to live life to the max. 'When you've had a life-threatening disease and you've lost two sisters then it brings it all to the forefront,' she mused. 'It makes you value life. You grab everything with both hands. Whenever I'm asked to do something I say yes straight away. When you come through it and you're at the other end and you think, well I didn't die and I'm alive and I'm gonna live every day.' Taking on that mantra, Anne is determined to tick some life plans off her extensive bucket list. It means for a busy few years, as she spells out her big plans 'I'd love to go and see the Vatican,' she smiles. 'I'd love to go to Nashville. I'd love to learn how to swim. I would love to learn a language, probably French or Spanish. And also learn an instrument. These are all the things I wished I had when I was younger.' She's also planning a trip down to stay with Coleen at her six-acre Staffordshire farm - but says don't expect her to be mucking out the animals. 'Coleen's place is absolutely gorgeous - but it's not for me,' laughes Anne. 'I can clean my whole house in a couple of hours. And although I love animals, I'm not good with them. I'm scared of most animals. I'm scared of dogs and I'm scared of cats. When I go to Coleen's farm, I go and see the horses and the goats but I couldn't be left alone with them.' She says her little sister is in her element there, and it's a joy to see. 'She absolutely loves it,' beams Anne. 'I remember when we were doing a tour with Frank Sinatra. Our opening night was in the Palais de Congress in Paris. She was nine at the time and we said to her, 'You can come with us with my mum and dad and then they can bring you home.' She said 'No I can't. I've got to muck out the horses at stables.' So from an early age she's always loved animals.' Coleen once described the cancer that impacted their family so acutely as a 'curse'. The Loose Women favourite herself was diagnosed with skin cancer in 2023 and brother Brian was told he had prostate cancer three days after Linda's funeral. Anne says she feels 'really well' despite the toll her body has been through over the pass couple of decades. 'I've got no aches and pains," insists Anne. "I don't take any medication at all. Now and again I might take an anxiety tablet but I don't take them regularly. I have neuropathy which I got from my chemotherapy. I have that in my feet and it's more of a sensation rather than a pain. Sometimes it wakes me up in the night. I'm able to do most things. I do my own housework. It's good considering I've had cancer twice.' Despite her all-clear, Anne says cancer will always be at the back of her mind. 'When you have cancer, it's one of those things that you kind of live with it for the rest of your life,' she says. 'You could kind of get a little bruise or a lump somewhere and you think, 'Oh my god, is that cancer?' It can always come back. "I get scared as well, and this is really stupid, but both my cancers I found when I was in the shower. So now in the shower I'm inclined not to be as good at looking for things as I'm frightened of finding something. It's really stupid because the thing is if you've got cancer, it's not going to go away. So the more you leave it, the less chance you've got of curing it.'
Daily Mirror
4 hours ago
- Daily Mirror
UKHSA issues vaccine alert over illness that can turn serious
This disease can even prove fatal, and one child died earlier this year Health experts have issued an urgent vaccine warning over an illness that can turn 'serious'. The UK Health Security Agency (UKHSA) is urging people to ensure their children are protected against measles. This call comes as the UK has seen a decline in the uptake of the MMR jab, which protects against measles, mumps and rubella, in recent years. As a result, many countries, including the UK, have seen a rise in measles cases. The disease, which is typically characterised by a rash, usually clears up after a week. But in serious cases it can go on to cause a number of dangerous complications such as pneumonia, meningitis, blindness and seizures (fits). This can even prove fatal and earlier this month it was reported that a child had died of measles in Liverpool. In an update posted to social media platform X, the UKHSA said: 'Measles can be a serious illness. 'More than one in 10 children haven't had the MMR vaccine and they need two doses to get full protection. Doses are usually given at one year old and three years four months old, but you can catch up missed doses later.' On its website, the UKHSA further warned that there were 2,911 laboratory confirmed measles cases in England last year, the highest number of cases recorded annually since 2012. Most of these cases were in unvaccinated children under the age of 10. There has also been a resurgence of measles in Europe after the COVID-19 pandemic. Measles cases in Europe doubled in 2024 compared to the previous year, with a staggering 127,350 reported cases. This figure represents the highest number since 1997. Outbreaks have been documented in several European nations, including France, Italy, Spain and Germany. The World Health Organisation (WHO) also disclosed that Romania, Pakistan, India, Thailand, Indonesia and Nigeria currently have among the largest number of measles cases globally. The importance of vaccines The UKHSA has linked the surge in cases across England to a decrease in vaccination rates. In a briefing earlier this year, it highlighted: "In England, the decline of the uptake of childhood vaccinations including MMR in the past decade (well below the WHO 95 per cent target) means that many thousands of children are left unprotected with the risk of outbreaks linked to nurseries and schools." London is at the bottom of the league for MMR vaccinations in comparison to other regions in England, with a five-year uptake rate of just 73.3 per cent against the English average of 83.9 per cent. The UKHSA warned: "The UKHSA is concerned that more outbreaks may occur again on a larger scale this summer as families with unvaccinated children and adults travel to countries where there are outbreaks. "It is important that anyone travelling for summer holidays or to visit family, especially parents of young children, check that all members of their family have received both their MMR vaccines." The first dose of MMR is currently offered to infants when they turn one and the second dose to pre-school children when they are around three years and four months old. This is due to change, however, so children turning one on July 1, and 18 months on January 1, 2026, will get their second MMR dose earlier - at 18 months instead of three years four months. Your GP surgery should contact you when your child is due the vaccine. You should speak to your GP surgery if: You have not been contacted to get your child's MMR vaccine Your child has missed their MMR vaccine, or you're not sure if they've had both doses of the vaccine You think you might need the MMR vaccine Your child has a temperature and is due to have the vaccine – they may need to wait until they're feeling better before having the vaccine You need to change a vaccination appointment Symptoms The primary indicators of measles include high fever, coughing, sneezing, red and sore watery eyes, followed by a rash after these initial symptoms. Without prompt attention, measles may result in severe and sometimes deadly complications such as pneumonia, meningitis, blindness, and seizures (fits). You should request an urgent GP appointment or ring 111 if you suspect that you or your child may have measles.
The Herald Scotland
4 hours ago
- The Herald Scotland
Researchers warn of 'quiet crisis' facing NHS Scotland
This "lifeblood of future healthcare innovation" is "quietly being drained away," with a reported 30% drop in the most active cohort over the past decade. They cite a complex combination of factors, including a lack of ring-fenced funding to train and support clinical researchers, inequalities that lead to challenges for female and minority researchers, competitive disadvantages compared to English institutions, and extensive time commitments required to complete training and enter the profession. Despite the challenges, the authors highlight the important contributions of Scotland's clinical researchers and what is potentially at risk of the trend of decline continues. "In economic terms, investment in medical research pays dividends—every £1 spent returns around £1.25 annually to the wider economy. "Scotland has long punched above its weight in this field. From pioneering bowel cancer screening programmes using the faecal immunochemical test (FIT), now central to early detection efforts worldwide, to the EAVE-II platform, which was instrumental in understanding vaccine effectiveness during COVID-19, our clinical academics have delivered innovations with national and global impact." Prof Rory McCrimmon, one of the authors of the letter and Dean of the School of Medicine at the University of Dundee, explained how these types of contributions are at risk of becoming increasingly scarce. He said that there are more academics over the age of 55 than under the age of 35. Clinical researchers now make up just 3% of the overall workforce, and only 0.6% of primary care workers are clinical researchers. Prof Rory McCrimmon has argued that clinical researchers need more practical and financial support in order to continue performing their life-saving work. (Image: University of Dundee) He added that the shrinking supply of clinical academics, combined with the baked-in challenges in the field, is adding immense stress on researchers. "It is undoubtedly harder to do out-of-programme research at the PhD or MD level, because obtaining funding for that is challenging. "Students leave university now with a larger amount of debt, and it takes a long time. It takes maybe ten to fifteen years to become a consultant. If you add a further three to five years of research on top of that, that's an incredibly long time to become a clinical academic. "I think it is also perceived to be really, really hard, because you are moving into a very competitive world." Read more: Prof Lorna Marson, Dean of Clinical Medicine at Edinburgh and a contributor to the open letter, said that clinical researchers have a significant impact on their patients and communities, in addition to their broader contributions to the economy and the field. "Research-active hospitals have better outcomes for their patients in terms of morbidity and mortality. "Also, engaging in clinical trials gives patients the opportunity to get expensive drugs for no cost. "There are many significant added values to being a patient in a research hospital, so we need to support that as much as we can." Prof Lorna Marson has said that barriers to people looking to break into clinical research should not distract from the passion that these academics have for their profession. (Image: University of Edinburgh) Prof Marson added that the decline in the number of clinical academics was not due to a lack of ambition in the profession and that better general support for researchers could make the career more feasible for many hopefuls. 'It's extraordinary that there are still a good number of people who want to do this. I think that demonstrates the huge commitment that people are bringing to this field, and therefore, we have to support them and help them if it's what they want to do. 'But it is exceptionally difficult for women who also want to have time out to have a family, or those who have caring responsibilities and wish to prolong their training. 'Using women as an example, we need to look for ways to support them not only to have time out to have families, but to undertake their research and continue in clinical academia. That is where we see the biggest drop-off, and it is not because they don't passionately want to stay. 'They just can't see a way through it.' All of this is against a backdrop of extreme competition for funding. Prof Ian McInnes CBE, co-author of the letter and Vice Principal and Head of College, College of Medical, Veterinary & Life Sciences at the University of Glasgow, called it a 'sadness' that young researchers are facing barriers to the profession at a time when there are many new opportunities on the horizon. 'Increasingly, academicians of the future will be data scientists. They'll be computing scientists. They'll be business scientists with MBAs and organisational design specialists. 'One of the ambitions I have for Scotland is that we actually become a model for an incredibly diverse community of academic clinicians with expertise in so many different areas.' Due to the interconnectedness of the UK higher education sector, Scottish researchers and institutions are in direct competition with their English counterparts. But different structures and priorities mean they are not always on an even playing field, Prof McInnes explained. In England, for example, the time of clinical academics is often divided evenly between clinical work and research. However, in Scotland, the divide is closer to 80% clinical and 20% research time. 'That 80% grows arms and legs, because clinical medicine is busier, clinical surgery is busier, clinical psychiatry is busier. So we're at a substantial disadvantage in Scotland compared to England.' There are also significant financial awards available only in England, which can further limit opportunities for Scottish researchers. Despite this, Prof McInnes was clear that the situation is not a case of finding fault. The different structures north and south of the border represent different strategies and priorities. The Scottish Government is currently pursuing health innovation projects through its Accelerated National Innovation Adoption (ANIA) Pathway, which focuses on developing and implementing new health technologies across NHS Scotland. The programme recently committed £6 million to a project helping people with type 2 Diabetes, stroke patients and babies born with a rare genetic condition. In the end, Prof McInnes said he and his colleagues are making a call to find collaborative solutions to a common problem and preserve what he called 'fabulous careers.' 'Clinical academics enrich and embellish the quality of clinical care, and they do that by being part of that community. 'There is very good evidence that just being in a clinical trial leads to better long-term outcomes for most chronic conditions. Even if you just get a placebo, you become a beneficiary of an ecosystem that seeks the best option, not the most convenient option. 'Being a clinical academic is an incredibly enriching profession, and part of our concern is that the focus on funding and crisis in the NHS obscures the fantastically brilliant career that is available.' Health Secretary Neil Gray said clinical research is "vital" for both the NHS and the economy. 'The need and case for this plan and its actions is timely – in recent years, the sector has suffered from the impact of Brexit and from UK Government immigration policies which have stemmed the flow of international talent into research programmes. 'We continue to provide over £.1.1billion to universities each year, including over £368million for research and innovation. Our Chief Scientist Office also continues to provide various funding opportunities for clinical research, working closely with our academic community to deliver clinical trials, develop new research and fast-track new innovations and technologies which benefit Scottish patients. 'However, we recognise the challenges and opportunities highlighted in the recent MRC report and we will continue to collaborate closely with universities, the NHS and industry to maximise opportunities for clinical academics here in Scotland.'
